P2Y4 receptor-mediated pinocytosis contributes to amyloid beta-induced self-uptake by microglia

Hui-quan Li1, Cong Chen, Ying Dou

  • 1Institute of Neuroscience and Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.

Insights

Adenosine triphosphate (ATP) acts as a "drink me" signal, activating pinocytosis in microglia via P2Y4 receptors. This finding reveals P2Y4 receptors as a potential therapeutic target for Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Immunology

Background:

  • Microglia, the brain's immune cells, respond to injury by releasing nucleotides.
  • P2Y12 and P2Y6 receptors mediate microglial chemotaxis and phagocytosis, respectively.
  • Pinocytosis in microglia remains less understood.

Purpose of the Study:

  • To investigate the role of adenosine triphosphate (ATP) in microglial pinocytosis.
  • To identify the specific purinergic receptors and signaling pathways involved in nucleotide-induced pinocytosis.
  • To explore the therapeutic potential of targeting these pathways in Alzheimer's disease.

Main Methods:

  • Utilized pharmacological analysis and knockdown experiments in microglia.
  • Investigated ATP-induced pinocytosis.
  • Examined the role of P2Y4 receptors and the phosphatidylinositol 3-kinase/Akt cascade.
  • Assessed the uptake of amyloid beta peptide 1-42 by microglia.

Main Results:

  • Adenosine triphosphate (ATP) was found to efficiently trigger pinocytosis in microglia.
  • P2Y4 receptors and the phosphatidylinositol 3-kinase/Akt signaling pathway were identified as key mediators.
  • Soluble amyloid beta peptide 1-42 induced microglial self-uptake via pinocytosis, involving P2Y4 receptor activation by autocrine ATP signaling.

Conclusions:

  • ATP functions as a novel "drink me" signal for microglia, initiating pinocytosis.
  • P2Y4 receptors are crucial for nucleotide-induced pinocytosis and amyloid beta uptake.
  • Targeting P2Y4 receptors presents a potential therapeutic strategy for Alzheimer's disease.